Advertisement

Ads Placeholder
Loading...

Personalis, Inc.

PSNLNASDAQ
Healthcare
Medical - Diagnostics & Research
$6.58
$0.02(0.30%)
U.S. Market opens in 19h 53m

Personalis, Inc. (PSNL) Stock Overview

Explore Personalis, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap584.3M
P/E Ratio-7.47
EPS (TTM)$-0.91
ROE-0.39%
Fundamental Analysis

AI Price Forecasts

1 Month$8.42
3 Months$8.85
1 Year Target$11.47

PSNL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Personalis, Inc. (PSNL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.89, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.47.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.47 and a market capitalization of 584.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.30%
5-Day Change
-9.37%
1-Month Change
-24.11%
3-Month Change
-16.18%
6-Month Change
-10.35%
Year-to-Date (YTD) Change
-16.18%
1-Year Change
99.39%
3-Year Change
135.00%
5-Year Change
-73.37%
All-Time (Max) Change
-76.90%

Contact Information

650 752 1300
1330 O’Brien Drive, Fremont, CA, 94025

Company Facts

2,280 Employees
IPO DateJun 20, 2019
CountryUS
Actively Trading

Frequently Asked Questions